Immunotoxicity induced in mice by subacute exposure to berberine

References

• Bendich, A. 1993. Physiological role of anti-oxidants in the immune system. J. Dairy Sci. 76:2789–2794
   PubMed Web of Science ®Google Scholar
• Byun, H. O., Kim, H. Y., Lim, J. J., et al. 2008. Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production. J. Cell Biochem. 104:1747–1759
   PubMed Web of Science ®Google Scholar
• Choi, B. H., Ahn, I. S., Kim, Y. H., et al. 2006. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp. Mol. Med. 38:599–605
   PubMed Web of Science ®Google Scholar
• Devadas, S., Zaritskaya, L., Rhee, S. G., et al. 2002. Discrete generation of superoxide and hydrogen peroxide by T-cell receptor stimulation: Selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 195:59–70
   PubMed Web of Science ®Google Scholar
• Endo, T., Ogushi, F., and Sone, S. 1996. LPS-dependent COX-2 induction in human monocytes is down-regulated by IL-13, but not by IFNγ. J. Immunol. 156:2240–2246
   PubMed Web of Science ®Google Scholar
• Endo, T., Ogushi, F., Kawano, T., and Sone, S. 1998. Comparison of the regulations by TH2-type cytokines of the arachidonic acid metabolic pathways in human alveolar macrophages and monocytes. Am. J. Respir. Cell Mol. Biol. 19:300–307
   PubMed Web of Science ®Google Scholar
• Fararjeh, M., Mohammad, M. K., Bustanji, Y., et al. 2008. Evaluation of immunosuppression induced by metronidazole in Balb/c mice and human peripheral blood lymphocytes. Intl. Immunopharmacol. 8:341–350
   PubMed Web of Science ®Google Scholar
• Farsam, V., Hassan, Z. M., Zavaran-Hosseini, A., et al. 2011. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ Treg cells in vivo. Int. Immunopharmacol. 11:1802–1808
   PubMed Web of Science ®Google Scholar
• Hasani-Ranjbar, S., Larijani, B., and Abdollahi, M. 2009. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm. Allergy Drug Targets 8:2–10
   PubMedGoogle Scholar
• Ivanovska, N., and Philipov, S. 1996. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions, and pure alkaloids. Int. J. Immunopharmacol. 18:553–561
   PubMed Web of Science ®Google Scholar
• Ivanovska, N., Philipov, S., and Hristova, M. 1999. Influence of berberine on T-cell-mediated immunity. Immunopharmacol. Immunotoxicol. 21:771–786
   PubMed Web of Science ®Google Scholar
• Jeong, H.W., Hsu, K. C., Lee, J. W., et al. 2009. Berberine suppresses pro-inflammatory responses through AMPK activation in macrophages. Am. J. Physiol. 296:E955–964
   PubMed Web of Science ®Google Scholar
• Kheir, M. M., Wang, Y., Hua, L., et al. 2010. Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem. Toxicol. 48:1105–1110
   PubMed Web of Science ®Google Scholar
• Laniewski, N. G., and Grayson, J. M. 2004. Anti-oxidant treatment reduces expansion and contraction of antigen-specific CD8+ T-cells during primary but not secondary viral infection. J. Virol. 78:11246–11257
   PubMed Web of Science ®Google Scholar
• Letasiova, S., Jantova, S., Muckova, M., and Theiszova, M. 2005. Anti-proliferative activity of berberine in vitro and in vivo. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149:461–463
   PubMedGoogle Scholar
• Li, Z., Geng, Y. N., Jiang, J. D., and Kong, W. J. 2014. Anti-oxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid.-Based Complement Alt. Med. 2014:289264
   PubMed Web of Science ®Google Scholar
• Lin, W. C., and Lin, J. Y. 2011. Five bitter compounds display different anti-inflammatory effects through modulating cytokine secretion using mouse primary splenocytes in vitro. J. Agric. Food Chem. 59:184–92
   PubMed Web of Science ®Google Scholar
• Los, M., Droge, W., Stricker, K., et al. 1995. Hydrogen peroxide as potent activator of T-lymphocyte functions. Eur. J. Immunol. 25:159–165
   PubMed Web of Science ®Google Scholar
• Lou, T., Zhang, Z., Xi, Z., et al. 2011. Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes. Inflammation 34:659–667
   PubMed Web of Science ®Google Scholar
• Luster, M. I., Dean, J. H., and Germolec, D. R. 2003. Consensus workshop on methods to evaluate developmental immunotoxicity. Environ. Health Perspect. 111:579–583
   PubMedGoogle Scholar
• Maemura, K., Zheng, Q., Wada, T., et al. 2005. Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells. Immunol. Cell. Biol. 83:336–343
   PubMed Web of Science ®Google Scholar
• Marinova, E. K., Nikolova, D. B., Popova, D. N., et al. 2000. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine. Immunopharmacology 48:9–16
   PubMed Web of Science ®Google Scholar
• Matsue, H., Edelbaum, D., Shalhevet, D., et al. 2003. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 171:3010–3018
   PubMed Web of Science ®Google Scholar
• Munder, M., Eichmann, K., Morán, J. M., et al. 1999. TH1/TH2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163:3771–3777
   PubMed Web of Science ®Google Scholar
• Noori, S., Taghikhani, M., Hassan, Z. M., et al. 2010. Tehranolide molecule modulates the immune response, reduce regulatory T-cell and inhibits tumor growth in vivo. Mol. Immunol. 47:1579–1584
   PubMed Web of Science ®Google Scholar
• Piganelli, J. D., Flores, S. C., Cruz, C., et al. 2002. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes 51:347–355
   PubMed Web of Science ®Google Scholar
• Rahnama, M., Mahmoudi, M., Zamani Taghizadeh Rabe, S., et al. 2014. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model. J. Immunotoxicol 12:231–238
   PubMed Web of Science ®Google Scholar
• Riahi, B., Rafatpanah, H., Mahmoudi, M., et al. 2010. Immunotoxicity of paraquat after subacute exposure to mice. Food Chem. Toxicol. 48:1627–1631
   PubMed Web of Science ®Google Scholar
• Riahi, B., Rafatpanah, H., Mahmoudi, M., et al. 2011. Evaluation of suppressive effects of paraquat on innate immunity in Balb/c mice. J. Immunotoxicol. 8:39–45
   PubMed Web of Science ®Google Scholar
• Sarna, L. K., Wu, N., Hwang, S. Y., et al. 2010. Berberine inhibits NADPH oxidase-mediated superoxide anion production in macrophages. Can. Physiol. Pharmacol. 88:369–378
   PubMed Web of Science ®Google Scholar
• Schieke, S. M., McCoy J. P., Jr and Finkel, T. 2008. Coordination of mitochondrial bioenergetics with G1 phase cell cycle progression. Cell Cycle 7:1782–1787
   PubMed Web of Science ®Google Scholar
• Sena Laura, A., Li, S., Jairaman, A., et al. 2013. Mitochondria are required for antigen-specific T-cell activation through reactive oxygen species signaling. Immunity 38:225–236
   PubMed Web of Science ®Google Scholar
• Smith-Garvin, J. E., Koretzky, G. A., and Jordan, M. S. 2009. T-Cell activation. Annu. Rev. Immunol. 27:591–619
   PubMed Web of Science ®Google Scholar
• Tsang, C. M., Cheung, Y. C., Lui, V. W., et al. 2013. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts. BMC Cancer 13:619
   PubMed Web of Science ®Google Scholar
• Xu, L., Liu, Y., and He, X. 2005. Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes. Cell. Mol. Immunol. 2:295–300
   PubMed Web of Science ®Google Scholar